FineHeart

Private

PessacHealthcare & Life Scienceshttps://fineheart.fr/

Last Round

Series C

Jan 9, 2026

Total Funding Raised

$75.41M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

FineHeart is a medical device company that has developed the FLOWMAKER®, a novel, wirelessly powered, fully implantable mechanical circulatory support device for severe heart failure patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

ICOMS FLOWMAKERheart failure deviceimplantable cardiac deviceheart pumpcardiac output acceleratorsevere heart failureLVAD alternativedriveline-freewireless rechargingMedTechminimally invasive procedureLeft Ventricular Assist DeviceLVADbeating-heart surgerytranscutaneous energy transferImplantable Cardiac Output Management SystemICOMSclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FineHeart Comparables

Compare FineHeart with similar companies based on industry and business-model similarity.

FineHeart comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

FineHeart Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Jan 9, 2026
Grant	Oct 19, 2022
Series B Extension	Dec 15, 2021
Series B	Jun 1, 2021
Series A	Mar 21, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

arnaud Mascarell

Chief Executive Officer and co-founder

Founding Team

Guillaume Buc

CTO, FineHeart

Executive Team

Sebastien Robitaille

CFO

Executive Team

FineHeart Investors

Notable investors and investment history

FineHeart investors
Investor	Rounds
European Innovation Council	Series C
Verve Ventures	Series B Extension, Series B
European Commission	Grant
Verve Capital	Series C
Aqui-Invest	Series A
Groupe Pasteur Mutualité	Series C
UI Investment	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 1, 2026
Monthly visitors grew 191% MoM, reaching 2.6K.
Jan 9, 2026
$41M round led by Aquiti Gestion and Galia Gestion.

View all signals

FineHeart Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

FineHeart Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FineHeart's valuation, stock price, and market status.

Firmographic Details

HeadquartersPessac

Employee Range87

Year Founded2010

Last FundingJan 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.